|
||||||||||||||||||||||||||||||||||||||||||||
Personal Web Pages of
Academic Staff |
|
|||||||||||||||||||||||||||||||||||||||||||
|
Associate Prof.Dr.
Sule APIKOGLU RABUS |
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
Contact Information
|
Ó
|
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
E-mail |
|
|||||||||||||||||||||||||||||||||||||||||||
Phone |
+90 216 346
40 60 |
|
||||||||||||||||||||||||||||||||||||||||||
Fax |
+90 216 345
29 52 |
|
||||||||||||||||||||||||||||||||||||||||||
Correspondence Address |
Marmara
Universitesi Eczacilik Fakultesi Klinik
Eczacilik Bilim Dalı Tibbiye Cad.
No. 49 Haydarpasa 34668 Istanbul / TURKEY |
|
||||||||||||||||||||||||||||||||||||||||||
Personal web page |
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Education
|
Ó
|
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
PhD |
2001 – 2007 :: Clinical
Pharmacy - Marmara University Faculty of Pharmacy, Istanbul – Turkey |
|
||||||||||||||||||||||||||||||||||||||||||
MSc |
1998 – 2001 :: Clinical
Pharmacy - Marmara University Faculty of Pharmacy, Istanbul – Turkey |
|
||||||||||||||||||||||||||||||||||||||||||
BSc |
1990 – 1995 :: Hacettepe University Faculty of Pharmacy, Ankara – Turkey |
|
||||||||||||||||||||||||||||||||||||||||||
Other |
1979 – 1990 :: TED
Ankara College Private High School, Ankara – Turkey |
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Professional Experience
|
Ó
|
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
Associate Professor |
2011 - ... |
Marmara
University, Faculty of Pharmacy, Clinical Pharmacy Department – Istanbul –
Turkey |
|
|||||||||||||||||||||||||||||||||||||||||
Assistant Professor |
2008 - 2011 |
Marmara
University, Faculty of Pharmacy, Clinical Pharmacy Department – Istanbul –
Turkey |
|
|||||||||||||||||||||||||||||||||||||||||
Freelance Translator |
2007 - 2008 |
Istanbul –
Turkey |
|
|||||||||||||||||||||||||||||||||||||||||
Research Assistant |
1999 - 2007 |
Marmara University, Faculty of Pharmacy, Clinical Pharmacy Department – Istanbul - Turkey |
|
|||||||||||||||||||||||||||||||||||||||||
Freelance Translator |
1997 - 1999 |
Istanbul –
Turkey |
|
|||||||||||||||||||||||||||||||||||||||||
Research Assistant |
1996 – 1997 |
Hacettepe University Faculty of Pharmacy, Department of
Pharmaceutical Technology - Ankara - Turkey |
|
|||||||||||||||||||||||||||||||||||||||||
Community
Pharmacist |
1995 - 1996 |
Managed my
owned pharmacy - Ankara - Turkey |
|
|||||||||||||||||||||||||||||||||||||||||
Trainee |
09.1994 – 10.1994 |
Hospital
Clínic i Provincial de Barcelona - Barcelona - Spain |
|
|||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
Publications
|
Ó
|
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
Dissertations
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
Ph.D. Thesis: Therapy-related issues in diabetics and the
effect of topical insulin on diabetic wound healing in rats. (Advisor: Prof.
Fikret V. Izzettin) |
|
||||||||||||||||||||||||||||||||||||||||||
|
M.Sc.
Thesis: A determination
of coronary heart disease lipid profiles and an evaluation of the costs and
indicators of effectiveness of thrombolytic therapy. (Advisor: Prof. Fikret
V. Izzettin) |
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
Book Chapters (International)
|
|
|||||||||||||||||||||||||||||||||||||||||||
1 |
Apikoglu-Rabus S,
Hursitoglu M, Yazici D, Izzettin FV. Assessment of quality of diabetes care for type 2 diabetics. In: Berhardt LV, editor. Advances in Medicine and Biology. Volume 25. New York: Nova Publishers;
2011.p.265-285. (ISBN: 978-1-61209-797-8) |
|
||||||||||||||||||||||||||||||||||||||||||
2 |
Sancar
M, Apikoglu-Rabus S, Clark PM, Izzettin FV. Role of the pharmacist in blood glucose monitoring. In: Berhardt LV, editor. Advances
in Medicine and Biology. Volume 25. New York: Nova Publishers;
2011.p.287-306. (ISBN: 978-1-61209-797-8) |
|
||||||||||||||||||||||||||||||||||||||||||
3 |
Clark PM, Apikoglu-Rabus
S, Kiran B, Karagoz T, Izzettin FV. A prospective assessment of
therapeutic efficacy and immune effects of levofloxacin and ofloxacin in
multiple-drug resistant tuberculosis. In: Ngụy S, K'ung Z, editors. Drug-Resistant Tuberculosis: Causes, Diagnosis and Treatments. New
York: Nova
Publishers; 2010. 237-249. (ISBN: 978-1-60876-055-8) |
|
||||||||||||||||||||||||||||||||||||||||||
4 |
Clark PM, Apikoglu-Rabus
S. Tuberculosis treatment failure: causes and solutions In: Ngụy S, K'ung Z, editors. Drug-Resistant Tuberculosis: Causes, Diagnosis and Treatments. New
York: Nova
Publishers; 2010 (ISBN: 978-1-60876-055-8) |
|
||||||||||||||||||||||||||||||||||||||||||
5 |
Hincal AA, Senel S, Calis
S, Apikoglu S. Presentation of the responses to the EAFP
questionnaire on developing teaching objectives in pharmaceutical
technology. In: Bourlioux P, Hincal AA, Senel S, Florence AT, editors.
Emerging themes and technologies in pharmacy education. Ankara: Safak Press;
1997.p.30-7. (ISBN No. 975-94740-0-X/978-975-94740-0-3) |
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Book Chapters (National)
|
|
|||||||||||||||||||||||||||||||||||||||||||
1 |
İzzettin FV, Sancar M, Acar Sancar A, Apikoğlu-Rabuş Ş. İlaç Yönetimi. H. Sur, T. Palteki, editörler. Hastane
Yönetimi. İstanbul: Nobel Tıp Kitabevleri; 2013.p.845-862. (ISBN:
978-975-420-950-1) |
|
||||||||||||||||||||||||||||||||||||||||||
2 |
İzzettin FV, Apikoğlu-Rabuş Ş,
Okuyan B, Sancar M. İlaç Güvenliği. H. Sur, T. Palteki, editörler. Hastane
Yönetimi. İstanbul: Nobel Tıp Kitabevleri; 2013.p. 561-576. (ISBN:
978-975-420-950-1) |
|
||||||||||||||||||||||||||||||||||||||||||
3 |
Apikoğlu-Rabuş Ş, Okuyan B. Tüberkülozdan Korunma. Yakıncı C, Yeşilada E, editörler.
Koruyucu Sağlık Rehberi. Ankara: Türk Eczacıları
Birliği Eczacılık Akademisi Yayınları; 2012.p.464-467. (ISBN:
978-605-60137-5-1) |
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
International Journals
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
1 |
Sener A, Egemen G, Cevik O, Yanikkaya-Demirel G,
Apikoglu-Rabus S, Ozsavci D. In
vitro effects of nitric oxide donors on apoptosis and oxidative/nitrative
protein modifications in ADP-activated platelets.”, Human and Experimental
Toxicology 2013; 32(3):225-235. |
|
||||||||||||||||||||||||||||||||||||||||||
2 |
Sener A, Cevik O, Yanikkaya-Demirel G, Apikoglu-Rabus S, Ozsavci D. Influence
of platelet γ-glutamyltransferase on oxidative stress and apoptosis in
the presence of holo-transferrin. Folia Biologica (Praha) 2012; 58(5):193-202. |
|
||||||||||||||||||||||||||||||||||||||||||
3 |
Apikoglu-Rabus S, Clark PM, Izzettin FV. Turkish pharmacists’ counseling practices and attitudes regarding emergency contraceptive pills. International Journal of Clinical Pharmacy 2012; 34(4), 579-586. |
|
||||||||||||||||||||||||||||||||||||||||||
4 |
Izzettin FV, Sancar M,
Okuyan B, Apikoglu-Rabus S, Cevikbas U. Comparison of protective
effects of various antiulcer agents alone or in combination on indomethacin induced
gastric ulcers in rats. Experimental and Toxicologic Pathology 2012;
64(4):339-343. |
|
||||||||||||||||||||||||||||||||||||||||||
5 |
Apikoglu-Rabus
S,
Sancar M, Okuyan B, Izzettin FV. Turkish pharmacy technicians’ counseling
practices and attitudes regarding emergency contraceptive pills. African Journal
of Pharmacy and Pharmacology 2011; 5:60-66. |
|
||||||||||||||||||||||||||||||||||||||||||
6 |
Hursitoglu M, Cikrikcioglu MA, Gundogan E, Ozkan
O, Cordan I, Yigit Y, Kara O, Soysal P, Apikoglu-Rabus
S, Celepkolu T, Tukek T. Rhabdomyolysis secondary to tetanus toxoid
administration in a patient following minor laceration. The Journal of Clinical Pharmacology 2011; 51:110-111. |
|
||||||||||||||||||||||||||||||||||||||||||
7 |
Sancar M, Hantash T, Okuyan B, Apikoglu-Rabus S, Cirakli Z,
Gulluoglu MG, Izzettin FV. Comparative effectiveness of Glycyrrhiza glabra vs. omeprazole and misoprostol for the
treatment of aspirin-induced gastric ulcers. African
Journal of Pharmacy and Pharmacology 2009; 3:615-620. |
|
||||||||||||||||||||||||||||||||||||||||||
8 |
Turnacilar
M, Sancar M, Apikoglu-Rabus S,
Hursitoglu M, Izzettin FV. Improvement of diabetes indices of
care by a short pharmaceutical care program. Pharm World Sci 2009; 31:689–695. |
|
||||||||||||||||||||||||||||||||||||||||||
9 |
Apikoglu-Rabus S, Izzettin FV, Turan P, Ercan F. Effect of topical insulin on cutaneous
wound healing in non-diabetic and acute diabetic rats. Clinical and
Experimental Dermatology (doi:10.1111/j.1365-2230.2009.03419.x). |
|
||||||||||||||||||||||||||||||||||||||||||
10 |
Apikoglu Rabus S, Izzettin FV, Sancar M, Karakaya O, Kargin R, Yakut C. Five-year
follow-up of drug utilization for secondary prevention in coronary artery
disease. Pharm World Sci 2008; 30:753-758. |
|
||||||||||||||||||||||||||||||||||||||||||
11 |
Clark PM, Karagoz T, Apikoglu Rabus
S, Izzettin FV: Effect of pharmacist-led patient education on adherence
to tuberculosis treatment. Am J Health Syst Pharm 2007; 64:497-505. |
|
||||||||||||||||||||||||||||||||||||||||||
12 |
Ayca B, Sener A, Apikoglu Rabus
S, Oba R. The effect of exercise on urinary gamma-glutamyl transferase
and protein levels of volleyball players. J Sports Med Phys Fitness 2006;46:623-7. |
|
||||||||||||||||||||||||||||||||||||||||||
13 |
Sancar M, Izzettin FV, Apikoglu
Rabus S, Besisik F, Tozun N, Dulger G. Pharmacoeconomic comparison of
Helicobacter Pylori eradication regimens. Pharm World Sci 2006;28:207-14. |
|
||||||||||||||||||||||||||||||||||||||||||
14 |
Apikoglu Rabus S, Izzettin FV, Rabus MB, Bilici M. Severe creatine kinase increase
during quetiapine and mirtazapine treatment. Psychopharmacology
2006;185:263-264. |
|
||||||||||||||||||||||||||||||||||||||||||
15 |
Apikoglu Rabus S, Izzettin FV, Sancar M, Rabus MB, Kırma C, Yakut C. Cost-effectiveness
of thrombolytics: a simplified model. Pharm World Sci 2005;27:243-248. |
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
National Journals
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
1 |
Clark PM, Macit C, Apikoglu-Rabus S, Cetin S, Sabuncu HH.
An assessment of the perceived effectiveness and safety of influenza vaccine.
Hacettepe University, Journal of the Faculty of Pharmacy 2011; 31(2):119-136. |
|
||||||||||||||||||||||||||||||||||||||||||
2 |
Sancar M, Okuyan B, Apikoglu-Rabus S, Izzettin FV.
Opinion and Knowledge Towards Pharmaceutical Care Of The Pharmacists
Participated in Clinical Pharmacy and Pharmaceutical Care Continuing
Education Program. Turkish Journal of Pharmaceutical Sciences, 10(3), (2013
sayısı için yayına kabul edilmiştir).
|
|
||||||||||||||||||||||||||||||||||||||||||
3 |
Aksoy H, Apikoglu-Rabus S, Uras F, Savci N,
Erseven G, Alatli C, Emekli N. Evaluation of the effect of fibrin glue
prepared from single-donor plasma on wound healing in rats. Hacettepe
University, Journal of the Faculty of Pharmacy 2009; 29:83-93. |
|
||||||||||||||||||||||||||||||||||||||||||
4 |
Izzettin
FV, Apikoglu Rabus S, Sancar M,
Eskisar A. Coronary artery disease prediction in men: use of apolipoproteins
A-I and B. FABAD J Pharm Sci 2005;30:134-140. |
|
||||||||||||||||||||||||||||||||||||||||||
5 |
Demirkan K,
Celiker A, Yilmaz D, Sancar M, Apikoglu
Rabus S, Izzettin FV, Sahin F. Improvement in pharmacists’ knowledge
through professional inservice education programs. FABAD J Pharm Sci 2004;29:117-120. |
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Invited Lectures, Workshops and Seminars
|
Ó
|
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
International
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
1 |
Apikoglu-Rabus S. Discrepancy between university education and daily
pharmacy practice in Turkey. 5th
European Meeting of Women Pharmacists, September 04-06, 2009;
Leipzig, Germany. |
|
||||||||||||||||||||||||||||||||||||||||||
2 |
Apikoglu-Rabus S. Factors Affecting
Quality of Life in Type 2 Diabetes. 9th Interntional Symposium of
Pharmaceutical Sciences, June 23-26, 2009; Ankara, Turkey. |
|
||||||||||||||||||||||||||||||||||||||||||
3 |
Clinical Pharmacy Workshop and Patient-Centred Teaching. WS leaders:
Izzettin FV; Nebioglu S. WS tutors: Demirkan K, Sancar M, Apikoglu-Rabus S, Bayraktar A. 9th
International Symposium on Pharmaceutical Sciences; June 23-26, 2009; Ankara, Turkey. |
|
||||||||||||||||||||||||||||||||||||||||||
4 |
Pharmacist Counseling on Herbal
Medicines and Dietary Supplements. WS leaders: Apikoglu-Rabus S, Clark PM, Soydeger B, Varol Y. 36th European
Symposium on Clinical Pharmacy, Istanbul, Turkey, 25-27 October 2007. |
|
||||||||||||||||||||||||||||||||||||||||||
5 |
Pharmaceutical Care in Diabetes. WS leaders: Apikoglu-Rabus S, Clark PM, Sancar M. 6th ESCP Spring Conference;
25-27 May 2006; Vilnius, Lithuania. |
|
||||||||||||||||||||||||||||||||||||||||||
6 |
How the pharmacist can be clinical competent in asthma management? WS
leaders: Sancar M, Clark PM, Apikoglu-Rabus
S. 6th ESCP Spring Conference; 25-27 May 2006; Vilnius, Lithuania. |
|
||||||||||||||||||||||||||||||||||||||||||
7 |
Clinical Pharmacy
Workshop and Patient-Centred Teaching. WS leaders: Izzettin FV, Hudson S; WS
tutors: Dessing RP, Nebioglu S; Demirkan K, Bayraktar A, Sancar M, Apikoglu-Rabus S. 8th International
Symposium on Pharmaceutical Sciences; June 14-15, 2006; Ankara, Turkey. |
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
National
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
1 |
Apikoğlu Rabuş Ş. Klinik Eczacılık ve Farmasötik Bakım. Yeditepe Yedikonu
Öğrenci Kongresi, 14 – 16 Ekim 2011, Yeditepe Üniversitesi, İstanbul. |
|
||||||||||||||||||||||||||||||||||||||||||
2 |
Apikoğlu Rabuş Ş. A Turkish
Vision for Clinical Pharmacy: Practice and Education.
Clinical Pharmacy Seminar, 12 May 2009, Marmara
University, İstanbul. |
|
||||||||||||||||||||||||||||||||||||||||||
3 |
Apikoğlu Rabuş Ş. Patient
Education
in Diabetes Mellitus. Seminar on Management of Diabetes Mellitus - Patient Focused Approaches, 20
April 2009, Yeditepe University, İstanbul. |
|
||||||||||||||||||||||||||||||||||||||||||
4 |
Apikoğlu Rabuş Ş (panelist). Panel:
Türkiye'de klinik eczacılık ve farmasötik bakım doğru anlaşıldı mı? Eğitim,
uygulamalar ve araştırmalara bakış. 9.
Türkiye Eczacılık Kongresi, 13 - 16
Kasım 2008, İstanbul. |
|
||||||||||||||||||||||||||||||||||||||||||
5 |
Apikoğlu Rabuş Ş. Hiperlipidemi tedavisinde eczacının rolü: Yakın Doğu Üniversitesi
Eczacılık Fakültesi Meslek-içi Eğitim Seminerleri, Nisan 2008, Lefkoşe-KKTC. |
|
||||||||||||||||||||||||||||||||||||||||||
6 |
Ulusoylu M, Toklu H, Apikoğlu
Rabuş Ş. Bitkisel ilaç kullanımında eczacı danışmanlığı. 1. Ulusal
Farmasötik Bakım ve Klinik Eczacılık Kongresi, İstanbul; 23-25 Eylül 2005. |
|
||||||||||||||||||||||||||||||||||||||||||
7 |
İzzettin FV, Sancar M, Apikoğlu-Rabuş
Ş. Üst solunum yolları enfeksiyonlarının
tedavisinde eczacının rolü. International Symposium on Pharmaceutical
Sciences, Ankara; 27 Haziran 2003. |
|
||||||||||||||||||||||||||||||||||||||||||
8 |
Apikoğlu-Rabuş Ş. Karar Ağacı. “Yöneticilere Farmakoekonomik Bakış Açısı Kazandırma”
Eğitim Programı (Birleşik Sağlık Sistemleri). Hilton Oteli, Istanbul; 26-27
Eylül 2002. |
|
||||||||||||||||||||||||||||||||||||||||||
9 |
Apikoğlu-Rabuş Ş. Karar Ağacı. “Yöneticilere Farmakoekonomik Bakış Açısı Kazandırma”
Eğitim Programı (Birleşik Sağlık Sistemleri). The Marmara, Istanbul; 17-18 Eylül
2002. |
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Presentations
|
Ó
|
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||
1 |
Rabus
MB, Atasoy B, Apikoglu-Rabus S,
Cayhan B, Fedakar A, Balkanay M. Tacrolimus-induced encephalopathy in a
heart transplant recipient in the absence of overdose. 8th
International Congress of Update in Cardiology and Cardiovascular Surgery
(UCCVS); Antalya, Turkey, 01-04 Mart 2012. |
|
||||||||||||||||||||||||||||||||||||||||||
2 |
Hursitoglu M, Tukek T, Cikrikcioglu MA, Yigit Y, Cakirca M, Zeren G, Apikoglu-Rabus S, Kara O, Cordan I,
Yetmis M, Soysal P. Cut-off point of waist circumference for the
diagnosis of metabolic syndrome in Turkish population. 10th Congress of the European Federation of
Internal Medicine; Athens, Yunanistan, 5-8 Ekim 2011. |
|
||||||||||||||||||||||||||||||||||||||||||
3 |
Apikoglu-Rabus S, Sancar M, Izzettin FV. How much do the faculty courses contribute to daily pharmacy practice?
. 39th European Symposium on Clinical Pharmacy; Lyon, France, 21-23 October
2010. [oral presentation] |
|
||||||||||||||||||||||||||||||||||||||||||
4 |
Apikoglu-Rabus S, Ture Z, Sancar M, Okuyan B, Soydeger-Carli B,
Yilmaz Z, Izzettin FV. Outcomes of diabetes
risk-testing performed at community pharmacy setting. 39th European Symposium
on Clinical Pharmacy; Lyon, France, 21-23 October 2010. [oral presentation] |
|
||||||||||||||||||||||||||||||||||||||||||
5 |
Apikoglu-Rabus S, Pakalpakcil O, Okuyan B, Sancar M, Soydeger-Carli
B, Izzettin FV. Characteristics of the drug-disease information
service demanded from the community pharmacist. 39th European Symposium on
Clinical Pharmacy; Lyon, France, 21-23 October 2010. |
|
||||||||||||||||||||||||||||||||||||||||||
6 |
Yildirim E, Apikoglu-Rabus S,
Yildiz P, Sancar M, Anil B, Izzettin FV. Effect of addition of montelukast to the asthma
maintenance treatment on the clinical and humanistic outcomes. 39th European
Symposium on Clinical Pharmacy; Lyon, France, 21-23 October 2010. |
|
||||||||||||||||||||||||||||||||||||||||||
7 |
Okuyan B, Gules M, Sancar M, Apikoglu-Rabus
S, Soydeger-Carli B, Izzettin FV.
Determination of knowledge and attitude of self-care among patients with
hypertension. 39th European Symposium on Clinical Pharmacy; Lyon, France,
21-23 October 2010. |
|
||||||||||||||||||||||||||||||||||||||||||
8 |
Sancar M, Akyildiz E, Okuyan B, Apikoglu-Rabus
S, Soydeger-Carli B, Yilmaz Z, Izzettin FV. Cardiovascular disease
risk assessment among patients with hyperlipidemia at a community pharmacy
setting. 39th European Symposium on Clinical Pharmacy; Lyon, France, 21-23
October 2010. |
|
||||||||||||||||||||||||||||||||||||||||||
9 |
Apikoglu-Rabus S, Koncagul MI, Okuyan B, Sancar M, Soydeger-Carli B, Izzettin FV.
Perceived job satisfaction of Turkish pharmacists. Proceedings: 3rd
International Meeting on Pharmacy and Pharmaceutical Sciences (IMPPC-3);
Istanbul, Turkey, 9-12 June, 2010. |
|
||||||||||||||||||||||||||||||||||||||||||
10 |
Apikoglu-Rabus S, Sancar M, Okuyan B, Izzettin FV. Turkish certified pharmacy
technicians’ counseling practices and attitudes regarding emergency
contraceptive pills. Proceedings: 3rd International Meeting on Pharmacy and Pharmaceutical
Sciences (IMPPC-3); Istanbul, Turkey, 9-12 June, 2010. |
|
||||||||||||||||||||||||||||||||||||||||||
11 |
Gunesdogdu
S, Apikoglu-Rabus S, Sancar M,
Izzettin FV. Characteristics of the drug-disease information service demanded
from the community pharmacist. Proceedings: 3rd International Meeting on
Pharmacy and Pharmaceutical Sciences (IMPPC-3); Istanbul, Turkey, 9-12 June,
2010. |
|
||||||||||||||||||||||||||||||||||||||||||
12 |
Aksoy H, Apikoglu-Rabus S,
Sancar M, Okuyan B, Uras F, Izzettin FV. The biochemical assessment of the
effects of Nigella sativa oil on cutaneous wound healing in rats.
Proceedings: 3rd International Meeting on Pharmacy and Pharmaceutical
Sciences (IMPPC-3); Istanbul, Turkey, 9-12 June, 2010. |
|
||||||||||||||||||||||||||||||||||||||||||
13 |
Okuyan B,
Kaya E, Sancar M, Apikoglu-Rabus S,
Soydeger-Carli B, Izzettin FV. Evaluation of dietary supplement consumption
at community pharmacy setting. Proceedings: 3rd International Meeting on Pharmacy
and Pharmaceutical Sciences (IMPPC-3); Istanbul, Turkey, 9-12 June, 2010. |
|
||||||||||||||||||||||||||||||||||||||||||
14 |
Soydeger-Carli
B, Kasap Y, Okuyan B, Apikoglu-Rabus S,
Sancar M, Izzettin FV. Assessment of the 5th grade pharmacy students’ opinions
on the first-time held ‘Pharmacy Practice I’ course of the second cycle.
Proceedings: 3rd International Meeting on Pharmacy and Pharmaceutical
Sciences (IMPPC-3); Istanbul, Turkey, 9-12 June, 2010. |
|
||||||||||||||||||||||||||||||||||||||||||
15 |
Apikoglu-Rabus
S, Izzettin FV, Turan P, Ercan F. Effect of
topical insulin on cutaneous wound healing in non-diabetic and acute diabetic
rats. Proceedings: 2009 ACCP/ESCP International Congress on Clinical Pharmacy; Orlando, Florida, USA,
24-28 April 2009. (Pharmacotherapy 2009; 29: 36e-173e). [BEST PAPER FINALIST - ORAL
PRESENTATION-] |
|
||||||||||||||||||||||||||||||||||||||||||
16 |
Apikoglu-Rabus S, Izzettin FV. Impact of a continuous professional development program on the counseling practices and attitudes of the pharmacists about emergency contraceptive pills. Proceedings: 2009 ACCP/ESCP International Congress on Clinical Pharmacy; Orlando, Florida, USA, 24-28 April 2009. (Pharmacotherapy 2009; 29: 36e-173e). |
|
||||||||||||||||||||||||||||||||||||||||||
17 |
Apikoglu-Rabus S,
Hursitoglu M, Bulgurlu SS, Dayan A, Yolcu N, Gebologlu N, Izzettin FV. Assessment
of quality of diabetes care for type 2 diabetics. Proceedings: 2009
ACCP/ESCP International Congress on Clinical Pharmacy; Orlando, Florida, USA,
24-28 April 2009. (Pharmacotherapy 2009; 29: 36e-173e). |
|
||||||||||||||||||||||||||||||||||||||||||
18 |
Izzettin FV,
Varol Y, Apikoglu-Rabus S,
Cevikbas A. Effects
of Nigella Sativa oil on cutaneous wound healing in rats. Proceedings: 2009 ACCP/ESCP
International Congress on Clinical Pharmacy; Orlando, Florida, USA, 24-28 April 2009. (Pharmacotherapy 2009; 29: 36e-173e). |
|
||||||||||||||||||||||||||||||||||||||||||
19 |
Clark PM, Apikoglu-Rabus S, Kiran B, Karagoz T, Izzettin FV. A prospective
assessment of therapeutic efficacy and immune effects of levofloxacin and
ofloxacin in multiple-drug resistant tuberculosis. (Pharmacotherapy 2009; 29: 36e-173e). [BEST PAPER FINALIST- ORAL
PRESENTATION] |
|
||||||||||||||||||||||||||||||||||||||||||
20 |
Ayca B, Apikoglu-Rabus S. Assessment of energy-drink and vitamin-mineral
combination supplement utilization profile of
athletes. 10th International Sport Sciences Congress, Bolu, Turkey, 23-25
October 2008. |
|
||||||||||||||||||||||||||||||||||||||||||
21 |
Apikoglu Rabus S, Izzettin FV. Fourth-grade pharmacy students prefer kinesthetic
learning. Proceedings: 36th European Symposium on Clinical Pharmacy –
Implementing Clinical Pharmacy in Community and Hospital Settings: Sharing
the Experience, Istanbul, Turkey, 25-27 October 2007. |
|
||||||||||||||||||||||||||||||||||||||||||
22 |
Ayca B, Apikoglu Rabus S.
Assessment of drug utilization profiles, attitudes and knowledge on
“performance enhancing drugs” among players of the amateur football league.
Proceedings: 36th European Symposium on Clinical Pharmacy – Implementing
Clinical Pharmacy in Community and Hospital Settings: Sharing the Experience,
Istanbul, Turkey, 25-27 October 2007. |
|
||||||||||||||||||||||||||||||||||||||||||
23 |
Cinemre-Solmaz NB, Burat K, Apikoglu
Rabus S. Cardiovascular drugs: prescription profiles and the economic
impact of a generic-based reimbursement system. Proceedings: 36th European
Symposium on Clinical Pharmacy – Implementing Clinical Pharmacy in Community
and Hospital Settings: Sharing the Experience, Istanbul, Turkey, 25-27
October 2007. |
|
||||||||||||||||||||||||||||||||||||||||||
24 |
Apikoglu Rabus S, Yurtseven SP, Guler O, Soydeger B, Rabus MB, Demircioglu SA,
Izzettin FV. The economic impact of a generic substitution based reimbursement
system for type 2 diabetes. Proceedings: 7th ESCP Spring Conference -
Tackling Inequalities in the Delivery of Pharmaceutical Care; Edinburgh, UK,
2007. |
|
||||||||||||||||||||||||||||||||||||||||||
25 |
Sancar M, Okuyan B, Apikoglu
Rabus S, Izzettin FV. Community pharmacists’ opinion on pharmaceutical
care practice in Turkey. Proceedings: 7th ESCP Spring Conference - Tackling
Inequalities in the Delivery of Pharmaceutical Care; Edinburgh, UK, 2007. |
|
||||||||||||||||||||||||||||||||||||||||||
26 |
Izzettin FV, Eminzade S, Apikoglu
Rabus S, Karagoz T. Quality of life in patients with tuberculosis.
Proceedings: 7th ESCP Spring Conference - Tackling Inequalities in the
Delivery of Pharmaceutical Care; Edinburgh, UK, 2007. [ORAL PRESENTATION] |
|
||||||||||||||||||||||||||||||||||||||||||
27 |
Apikoglu Rabus S, Izzettin FV, Sancar M, Karakaya O, Kargin R, Yakut C. Mid-term
results of secondary prevention in coronary artery disease: drug utilization profiles.
Proceedings: 6th ESCP Spring Conference - Chronic Disease Management: the
Role of the Pharmacist; Vilnius, Lithuania, 25-27 May 2006. [ORAL PRESENTATION] |
|
||||||||||||||||||||||||||||||||||||||||||
28 |
Apikoglu Rabus S, Bozkurt E, Demircioglu C, Tandogan S, Aydın D, Uzel G, Izzettin FV.
Prevalence of patient reported adverse effects of statins – particular
emphasis on myalgia. Proceedings: 6th ESCP Spring Conference - Chronic
Disease Management: the Role of the Pharmacist; Vilnius, Lithuania, 25-27 May
2006. |
|
||||||||||||||||||||||||||||||||||||||||||
29 |
Apikoglu Rabus S, Dincer A, Donmez F, Ekiz A, Guler O, Reiazi B, Izzettin FV. Patient-
counseling practices and attitudes of pharmacy staff and pharmacy students on
emergency contraception pills. Proceedings: 6th ESCP Spring Conference -
Chronic Disease Management: the Role of the Pharmacist; Vilnius, Lithuania,
25-27 May 2006. |
|
||||||||||||||||||||||||||||||||||||||||||
30 |
Izzettin FV, Apikoglu Rabus S,
Sancar M, Gebologlu N, Hursitoglu M. Cardiovascular Drug Prescription in Type
2 Diabetes. Proceedings: 34th European Symposium on Clinical Pharmacy –
Patient Profiling: Key to Successful Treatment; Amsterdam, the Netherlands,
26-29 October 2005. (Pharm World Sci 2007; 29: 431-515) |
|
||||||||||||||||||||||||||||||||||||||||||
31 |
Apikoglu Rabus S, Izzettin FV, Rabus MB, Bilici M. Massive Creatine Kinase Increase
during Quetiapine and Mirtazapine Treatment. Proceedings: 34th European Symposium
on Clinical Pharmacy – Patient Profiling: Key to Successful Treatment;
Amsterdam, the Netherlands, 26-29 October 2005. (Pharm World Sci 2007; 29:
431-515) |
|
||||||||||||||||||||||||||||||||||||||||||
32 |
Apikoglu Rabus S, Sancar M, Eskisar A, Turan F, Yakut C, Izzettin FV. Prescription
profiles in primary and secondary coronary artery disease prevention.
Proceedings: 33rd European Symposium on Clinical Pharmacy – Risk Management
in Pharmacotherapy; Prague, Czech Republic, 20-23 October 2004. (Pharm World
Sci 2005; 27: A1-A123) |
|
||||||||||||||||||||||||||||||||||||||||||
33 |
Izzettin FV, Apikoglu Rabus S,
Mutlu B, Basaran Y, Yakut C. Predictors of coronary artery disease in Turkish
subjects. Proceedings: 33rd European Symposium on Clinical Pharmacy – Risk
Management in Pharmacotherapy; Prague, Czech Republic, 20-23 October 2004.
(Pharm World Sci 2005; 27: A1-A123) |
|
||||||||||||||||||||||||||||||||||||||||||
34 |
Turnacilar M, Sancar M, Apikoglu
Rabus S, Izzettin N, Turnacilar E, Izzettin FV. Outcomes of
pharmaceutical care in type 2 diabetes: patient education and monitoring.
Proceedings: 33rd European Symposium on Clinical Pharmacy – Risk Management
in Pharmacotherapy; Prague, Czech Republic, 20-23 October 2004. (Pharm World
Sci 2005; 27: A1-A123). [ORAL
PRESENTATION] |
|
||||||||||||||||||||||||||||||||||||||||||
35 |
Demirkan K, Yilmaz D, Sancar M, Izzettin FV, Apikoglu Rabus S. Improvement of pharmacists’ knowledge with continuing
education programs. Proceedings: 2nd Joint Meeting ESCP-ACCP: Optimizing
Outcomes in Pharmacotherapy; Paris, France, 28-30 April 2004. (Pharm World
Sci 2004; 26: A1-A135). [ORAL
PRESENTATION] |
|
||||||||||||||||||||||||||||||||||||||||||
36 |
Apikoglu Rabus S, Izzettin FV, Rabus MB, Yakut C. Cost-effectiveness of tissue
plasminogen activator vs streptokinase: a hospital study in Turkey.
Proceedings: 31st European Symposium on Clinical Pharmacy - Innovation in
Drug Therapy and Health Policy - Patient's Rights and Economic Constraints;
Florence, Italy, 30 October - 2 November 2002. (Pharm World Sci 2003; 25:
81-114) |
|
||||||||||||||||||||||||||||||||||||||||||
23
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Lecture Notes in Turkish |
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
1 |
Kronik Hastalıklarda
Eczacı Danışmanlığı ve Klinik Eczacılık Seminerleri I – Klinik Eczacılık ve Farmasötik
Bakımın Temelleri – Ders Notları - 2006 Klinik Eczacılık Derneği – F.V.
İzzettin, M. Sancar, Ş. Apikoğlu Rabuş, B. Okuyan |
|
||||||||||||||||||||||||||||||||||||||||||
2 |
Kronik Hastalıklarda Eczacı
Danışmanlığı ve Klinik Eczacılık Seminerleri II – Diyabette Farmasötik Bakım
– Ders Notları - 2007 Klinik Eczacılık Derneği – F.V. İzzettin, M. Sancar, Ş.
Apikoğlu Rabuş, B. Okuyan |
|
||||||||||||||||||||||||||||||||||||||||||
3 |
Endokrin ve Romatizmal
Hastalıklar Ders Notları - Türk Eczacıları Birliği Eczacılık Akademisi – F.V.
İzzettin, K. Demirkan, M. Sancar, A. Bayraktar, Ş. Apikoğlu-Rabuş |
|
||||||||||||||||||||||||||||||||||||||||||
4 |
İnfeksiyon
Hastalıkları Ders Notları - Türk Eczacıları Birliği Eczacılık Akademisi –
F.V. İzzettin, K. Demirkan, M. Sancar, A. Bayraktar, Ş. Apikoğlu-Rabuş |
|
||||||||||||||||||||||||||||||||||||||||||
5 |
İyi Eczacılık
Uygulamaları – Klinik Eczacılık ve Farmasötik Bakım Semineri - Türk
Eczacıları Birliği Eczacılık Akademisi – F.V. İzzettin, K. Demirkan, M.
Sancar, A. Bayraktar, Ş. Apikoğlu-Rabuş |
|
||||||||||||||||||||||||||||||||||||||||||
6 |
Eczane
Teknisyeni Eğitim Programı “ET 112 Uygulamalar Modülü” - Türk Eczacıları
Birliği Eczacılık Akademisi – F.V. İzzettin, M. Sancar, Ş.
Apikoğlu-Rabuş |
|
||||||||||||||||||||||||||||||||||||||||||
7 |
Hacettepe
Üniversitesi Eczacılık Fakültesi - 1996-1997 Bahar Yarıyılı – ECF 436 Klinik
Eczacılık Ders Notları – Şule Apikoğlu, Ayçe Çeliker |
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Other Activities
|
Ó
|
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
Journal
of Marmara University Institute Health Sciences (MUSBED) (2011 - …): Language editor |
|
||||||||||||||||||||||||||||||||||||||||||
|
Türkiye Klinikleri Journal of Pharmacy
Sciences (2012 - …): Scientific
Advisory Board Member |
|
||||||||||||||||||||||||||||||||||||||||||
|
Marmara
Pharmaceutical Journal (2011 - …): Scientific
Advisory Board Member |
|
||||||||||||||||||||||||||||||||||||||||||
|
World Journal of Pharmacology (2011 -
…): Editorial Board Member |
|
||||||||||||||||||||||||||||||||||||||||||
|
Şişli Etfal Training and Research Hospital Ethics Committee for
Clinical Research (2012 - 2013):
Member |
|
||||||||||||||||||||||||||||||||||||||||||
|
Ulusal
Eczacılık Eğitimi Akreditasyon Kurulu (ECZAK) - National Accreditation
Council for Pharmacy Education: Member |
|
||||||||||||||||||||||||||||||||||||||||||
|
Marmara University
Faculty of Pharmacy (2012 - 2013): Faculty Board Member |
|
||||||||||||||||||||||||||||||||||||||||||
|
Marmara University
Faculty of Pharmacy LLP/Erasmus Commission (2010 - ...): Assistant
coordinator |
|
||||||||||||||||||||||||||||||||||||||||||
|
Marmara University
Faculty of Pharmacy Training Commission (2009 - ...): Member |
|
||||||||||||||||||||||||||||||||||||||||||
|
Marmara University
Pharmaceutical Care Unit (2004 - ...): Executive Committee Member |
|
||||||||||||||||||||||||||||||||||||||||||
|
Marmara University
Pharmaceutical Care Unit (2008 - ...): Clinical and Education Coordinator |
|
||||||||||||||||||||||||||||||||||||||||||
|
I. National Pharmaceutical Care and Clinical Pharmacy Congress -
Istanbul, Turkey, 2005: Organizing
Committee Member |
|
||||||||||||||||||||||||||||||||||||||||||
|
36th European Symposium on Clinical Pharmacy - Istanbul, Turkey,
25-27 October 2007: Organizing
Committee Member |
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Research Areas
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
Pharmacotherapy;
pharmaceutical care and risk management, particularly in: Cordiometabolic
Disorders |
|
||||||||||||||||||||||||||||||||||||||||||
|
Pharmacoeconomics |
|
||||||||||||||||||||||||||||||||||||||||||
|
Pharmacy
Education |
|
||||||||||||||||||||||||||||||||||||||||||
|
Dietary Supplements and Herbal
Medicines |
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Other
|
Ó
|
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Language skills |
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
TOEFL Score 263
CBT (Computer-based TOEFL) = 623 (Paper-based TOEFL) |
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Membership of professional
bodies |
|
|||||||||||||||||||||||||||||||||||||||||||
|
·
European Society of
Clinical Pharmacy (ESCP) ·
Turkish Society of
Clinical Pharmacy ·
International
Society for Pharmacoeconomics and Outcomes Research (ISPOR) ·
Turkish
Pharmacists’ Association (TEB)
·
Pharmacists' Chamber
of Istanbul (IEO) ·
Association
of Pharmaceutical Sciences of Ankara (FABAD)
·
Turkish
Pharmaceutical Technology Scientists' Association (TÜFTAD)Turkey, |
|
||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
Ó
|
|
||||||||||||||||||||||||||||||||||||||||||
|
C
|
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||